Goldstream Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,582
Closed -$534K 42
2025
Q4
$534K Hold
2,582
0.19% 36
2025
Q3
$479K Hold
2,582
0.11% 33
2025
Q2
$394K Hold
2,582
0.13% 36
2025
Q1
$428K Hold
2,582
0.19% 26
2024
Q4
$373K Sell
2,582
-3,289
-56% -$510K 0.1% 29
2024
Q3
$951K Buy
+5,871
New +$935K 0.32% 28
2023
Q4
Sell
-2,458
Closed -$383K 43
2023
Q3
$383K Hold
2,458
0.3% 25
2023
Q2
$407K Buy
2,458
+1,297
+112% +$209K 0.29% 22
2023
Q1
$180K Buy
+1,161
New +$187K 0.19% 26

Other funds holding JNJ

Goldstream Capital Management's JNJ Position: Q1 2026 in Review

Goldstream Capital Management sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 2,582 shares — an estimated $534K sold.

Goldstream Capital Management first reported a position in JNJ in Q1 2023 and held it in 9 quarters. The position peaked at $951K in Q3 2024. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Goldstream Capital Management reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Goldstream Capital Management sold 2,582 Johnson & Johnson shares in Q1 2026, an estimated $534K.
  • Goldstream Capital Management first reported a position in Johnson & Johnson in Q1 2023 and held it in 9 quarters.
  • Goldstream Capital Management's Johnson & Johnson position peaked at $951K in Q3 2024.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Goldstream Capital Management's 13F filing for Q1 2026, filed 15 May 2026.